Pko Investment Management Joint Stock CO Amgen Inc Transaction History

Pko Investment Management Joint Stock CO

$1.17 Trillion
Q3 2025

A detailed history of Pko Investment Management Joint Stock CO transactions in Amgen Inc stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 38,660 shares of AMGN stock, worth $13 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

38,660

Previous 35,260 9.64%

Holding current value

$13 Million

Previous $9.84 Billion 10.82%

% of portfolio

0.93%

Previous 1.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$271.18 - $309.22 $922,012 - $1.05 Million	3,400 Added 9.64%	38,660 $10.9 Billion
Q2 2025 Jul 31, 2025	BUY	$262.28 - $309.85 $6.99 Million - $8.26 Million	26,660 Added 310.0%	35,260 $9.84 Billion
Q1 2025 Apr 18, 2025	SELL	$258.59 - $327.36 $3.41 Million - $4.32 Million	-13,200 Reduced 60.55%	8,600 $2.68 Billion
Q4 2024 Mar 13, 2025	BUY	$258.78 - $328.31 $5.64 Million - $7.16 Million	21,800 New	21,800 $5.68 Billion
Q3 2024 Mar 13, 2025	SELL	$309.38 - $337.38 $92,814 - $101,214	-300 Reduced 3.16%	9,200 $2.96 Billion
Q2 2024 Mar 13, 2025	SELL	$262.75 - $319.31 $420,400 - $510,896	-1,600 Reduced 13.56%	10,200 $3.19 Billion
Q1 2024 Mar 13, 2025	BUY	$268.87 - $324.56 $1.44 Million - $1.74 Million	5,370 Added 83.51%	11,800 $3.37 Billion
Q4 2023 Mar 13, 2025	BUY	$255.7 - $288.46 $784,999 - $885,572	3,070 Added 47.74%	9,500 $2.74 Billion
Q3 2023 Mar 13, 2025	SELL	$218.65 - $271.46 $5.41 Million - $6.71 Million	-24,733 Reduced 90.82%	2,500 $672 Million
Q2 2023 Mar 13, 2025	BUY	$214.27 - $253.37 $2.19 Million - $2.59 Million	10,233 Added 60.19%	27,233 $6.05 Billion
Q1 2023 Mar 13, 2025	BUY	$225.79 - $275.2 $2.71 Million - $3.3 Million	12,000 Added 240.0%	17,000 $4.11 Billion
Q4 2022 Mar 13, 2025	SELL	$229.03 - $291.01 $572,575 - $727,525	-2,500 Reduced 41.67%	3,500 $919 Million
Q3 2022 Mar 13, 2025	SELL	$224.46 - $253.15 $3.55 Million - $4 Million	-15,800 Reduced 72.48%	6,000 $1.35 Billion
Q2 2022 Mar 13, 2025	SELL	$230.71 - $256.74 $461,420 - $513,480	-2,000 Reduced 28.57%	5,000 $1.22 Billion
Q1 2022 Mar 13, 2025	SELL	$219.27 - $242.57 $4.11 Million - $4.55 Million	-18,758 Reduced 72.82%	7,000 $1.69 Billion
Q4 2021 Mar 13, 2025	BUY	$198.88 - $227.6 $1.4 Million - $1.6 Million	7,020 Added 37.46%	25,758 $5.79 Billion
Q3 2021 Mar 13, 2025	BUY	$212.27 - $248.7 $925,072 - $1.08 Million	4,358 Added 30.31%	18,738 $3.98 Billion
Q2 2021 Mar 13, 2025	BUY	$233.58 - $259.14 $1.86 Million - $2.06 Million	7,950 Added 123.64%	14,380 $3.51 Billion
Q4 2020 Mar 13, 2025	SELL	$216.38 - $257.67 $3.33 Million - $3.96 Million	-15,370 Reduced 70.5%	6,430 $1.48 Billion
Q3 2019 Mar 13, 2025	SELL	$174.11 - $208.62 $2.68 Million - $3.21 Million	-15,370 Reduced 70.5%	6,430 $1.24 Billion
Q3 2018 Mar 13, 2025	SELL	$185.29 - $208.89 $2.85 Million - $3.21 Million	-15,370 Reduced 70.5%	6,430 $1.33 Billion
Q2 2018 Mar 13, 2025	BUY	$166.05 - $186.51 $1 Million - $1.12 Million	6,025 Added 1487.65%	6,430 $1.19 Billion
Q1 2018 Mar 13, 2025	SELL	$169.43 - $198.0 $1.74 Million - $2.03 Million	-10,243 Reduced 96.2%	405 $69 Million
Q4 2017 Mar 13, 2025	BUY	$168.79 - $188.59 $346,525 - $387,175	2,053 Added 23.89%	10,648 $1.85 Billion
Q3 2017 Mar 13, 2025	BUY	$167.29 - $191.0 $427,258 - $487,814	2,554 Added 42.28%	8,595 $1.6 Billion
Q2 2017 Mar 13, 2025	BUY	N/A	3,640 Added 151.6%	6,041 $1.04 Billion
Q1 2017 Mar 13, 2025	BUY	N/A	1,934 Added 414.13%	2,401 $394 Million
Q4 2016 Mar 13, 2025	SELL	N/A	-21,333	467 $68.3 Million

Others Institutions Holding AMGN

# of Institutions

3,274

Shares Held

427M

Call Options Held

6.49M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $180B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pko Investment Management Joint Stock CO, based on Form 13F filings with the SEC.

News

Stay updated on Pko Investment Management Joint Stock CO with notifications on news.

Account

Pko Investment Management Joint Stock CO Amgen Inc Transaction History